Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Jaguar Health (JAGX) Short-term Investments (2025)

Jaguar Health (JAGX) has disclosed Short-term Investments for 1 consecutive years, with $6.9 million as the latest value for Q4 2025.

Quarterly Short-term Investments changed N/A to $6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $6.9 million for FY2025, N/A changed from the prior year.
Short-term Investments for Q4 2025 was $6.9 million at Jaguar Health.
The five-year high for Short-term Investments was $6.9 million in Q4 2025, with the low at $6.9 million in Q4 2025.